| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $124K | +499.0% |
| Cost of Revenue | $21K | -59.6% |
| Gross Profit | $103K | +422.9% |
| R&D Expense | $7.7M | -7.9% |
| SG&A Expense | $6.3M | +17.6% |
| Operating Income | -$14.0M | -1.1% |
| Pre-tax Income | -$14.8M | +0.6% |
| Income Tax | $800 | +0.0% |
| Net Income | -$14.8M | +0.6% |
| EPS (Basic) | -$3.46 | -121.8% |
| EPS (Diluted) | -$3.46 | -121.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $417K | -89.3% |
| Accounts Receivable | $22 | -60.7% |
| Inventory | $296K | +105.6% |
| Current Assets | $1.1M | -73.7% |
| Total Assets | $20.9M | -27.6% |
| Current Liabilities | $1.1M | -72.7% |
| Total Liabilities | $13.3M | +0.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.6M | +20.5% |
| Capital Expenditures | $35K | +62.0% |
| Investing Cash Flow | -$2K | +98.2% |
| Financing Cash Flow | $1.0M | -87.4% |
| Free Cash Flow | -$4.6M | +20.2% |
| $7.6M |
| -51.3% |